To this end, we conjugated MiniAp-4 to Tz, which is widely usedto treat breast cancer.36,37 Although some reportsdescribe a limited degree of brain penetration for Tz,38,39 its low efficacy in the treatment of HER2+ BM is most likely relatedto the poor brain penetration. Here, ERBB2 is linked to breast carcinoma.